Mercado de equipamentos de descongelação de terapia celular e genética da América do Norte – Tendências do setor e previsão para 2028

Análise de mercado e insights: Mercado de equipamentos de descongelação para terapia celular e genética da América do Norte

Espera-se que o mercado de equipamentos de descongelação de terapia celular e genética ganhe crescimento de mercado no período de previsão de 2021 a 2028. A Data Bridge Market Research analisa que o mercado está a crescer com um CAGR de 14,4% no período de previsão de 2021 a 2028 e prevê-se que atinja os 745,08 milhões de dólares até 2028. O aumento de casos de doenças genéticas, como doenças cardíacas, fibrose quística e SIDA, exige o avançado equipamento de descongelamento de terapia celular e genética, atuando assim como impulsionador para o crescimento do mercado de equipamentos de descongelação de terapia celular e genética.

Os equipamentos de descongelação de terapia celular e genética tornaram-se fáceis devido ao avanço da tecnologia, uma vez que vários dos principais players do mercado estão a desenvolver e a lançar novas soluções para expandir o seu mercado. Além disso, o aumento dos gastos em saúde nos países desenvolvidos, bem como nos países em desenvolvimento, alimentou o crescimento do mercado de equipamentos de descongelação para terapia celular e genética. O mercado de equipamentos de descongelação para terapia celular e genética está a crescer devido ao aumento da incidência de doenças crónicas e ao aumento do avanço tecnológico.

O aumento da prevalência de doenças crónicas atua como impulsionador do mercado de equipamentos de descongelação para terapia celular e genética. O aumento do custo associado à engenharia de terapia celular e genética reduz a procura de equipamentos de descongelação de terapia celular e genética, o que está a restringir o crescimento do mercado de equipamentos de descongelação de terapia celular e genética. O aumento dos novos avanços tecnológicos atua como uma oportunidade para o mercado de equipamentos de descongelação de terapia celular e genética. No entanto, a falta de acessibilidade nos países de baixo e médio rendimento atua como um desafio para o crescimento do mercado de equipamentos de descongelação de terapia celular e genética.

The cell and gene therapy thawing equipment market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the cell and gene therapy thawing equipment market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Cell and Gene Therapy Thawing Equipment Market Scope and Market Size

The cell and gene therapy thawing equipment market is segmented on the based on the modality, sample, type, application, end user, distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

• On the basis of sample, the cell and gene therapy thawing equipment market is segmented into cell therapies and gene therapies. In 2021, the cell therapy segment is expected to dominate the cell and gene therapy thawing equipment market due to rising prevalence and incidence of cancer. 
• On the basis of type, the cell and gene therapy thawing equipment market is segmented into manual thawing system and automatic thawing system. In 2021, the automatic thawing system segment is expected to dominate the cell and gene therapy thawing equipment market as it improves reproducibility and minimizes human error. 
• On the basis of application, the cell and gene therapy thawing equipment market is segmented into upstream processing and downstream processing. In 2021, the upstream processing segment is expected to dominate the cell and gene therapy thawing equipment market due to rising technological advancements in the thawing systems. 
• On the basis of end user, the cell and gene therapy thawing equipment market is segmented into blood banks and transfusion centers, hospitals and diagnostic laboratories, research laboratories and academic institutes, biotechnology and pharmaceutical industry, cord blood and stem cell banks, gene banks and others. In 2021, the blood banks segment is expected to dominate the Cell and gene therapy thawing equipment market due to rise in number of blood banks and advanced healthcare providers in low and middle income countries.
• On the basis of distribution channel, the cell and gene therapy thawing equipment market is segmented into direct tender, third part distributor and others. In 2021, the direct tender segment is expected to dominate the cell and gene therapy thawing equipment market as majority of healthcare provider’s procured cell and gene therapy thawing equipment right from direct tender.

Cell and Gene Therapy Thawing Equipment Market Country Level Analysis

The cell and gene therapy thawing equipment market is segmented on the based on the modality, sample, type, application, end user, distribution channel.

The countries covered in the cell and gene therapy thawing equipment market report are the U.S., Canada and Mexico.  

The U.S., is expected to dominate the North American region because of increasing prevalence of chronic diseases.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Growing Strategic Activities by Major Market Players to Enhance the Awareness for Cell and Gene Therapy Thawing Equipment, is Boosting the Market Growth of Cell and Gene Therapy Thawing Equipment Market

The cell and gene therapy thawing equipment market also provides you with detailed market analysis for every country growth in particular market. Additionally, it provides the detail information regarding the market players’ strategy and their geographical presence. The data is available for historic period 2010 to 2019.

Competitive Landscape and Cell and Gene Therapy Thawing Equipment Market Share Analysis

Cell and gene therapy thawing equipment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to cell and gene therapy thawing equipment market.

The major companies which are dealing in the cell and gene therapy thawing equipment are Pluristem Therapeutics Inc., Genesis BPS, Eppendorf AG, Cytiva (A subsidiary of Danaher Corporation), Glenmark Pharmaceutical Inc., USA (A subsidiary of Glenmark), EDGE pharma, Cook, SARSTEDT AG & Co. KG, Barkey, Boekel Scientific, LABCOLD, Sartorious AG and Helmer Scientific Inc. among others domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many contract and agreement are also initiated by the companies’ worldwide which are also accelerating the cell and gene therapy thawing equipment market.

For instance,

• Em novembro de 2020, a Eppendorg AG lançou o SmartBlock para descongelação de células na Índia. O Smart Block Cell Thawing é uma base para o processamento a jusante. É fácil e conveniente para os cientistas utilizarem posteriormente em todos os laboratórios de manipulação de células.

A colaboração, o lançamento de produtos, a expansão de negócios, a premiação e o reconhecimento, as joint ventures e outras estratégias do player de mercado estão a aumentar a presença da empresa no mercado de equipamentos de descongelação de terapia celular e genética, o que também oferece o benefício para o crescimento do lucro da organização.

SKU-65776